{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T10:29:38Z","timestamp":1777804178390,"version":"3.51.4"},"reference-count":53,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T00:00:00Z","timestamp":1499644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Child Neurol"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:p>The human papillomavirus (HPV) vaccine is efficacious in preventing complications of human papillomavirus infection including cervical cancer. However, there have been case reports of adverse events occurring after vaccination, one being postural orthostatic tachycardia syndrome (POTS). This article reviews published data and other available information regarding the relationship between the human papillomavirus vaccine and POTS. Background information is provided regarding the human papillomavirus vaccine and the proposed post-vaccination adverse event POTS. Peer-reviewed literature, statements by government and medical advisory committees, and publicly available information published on this topic are examined. At this time, there is no conclusive evidence supporting a causal relationship between the human papillomavirus vaccine and POTS. Though a causal relationship has been postulated, it is of utmost importance to recognize that while temporal associations may be observed, conclusions of causality cannot be drawn from case reports and case series due to the small sample size and lack of control population.<\/jats:p>","DOI":"10.1177\/0883073817718731","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T03:02:02Z","timestamp":1504839722000},"page":"956-965","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":29,"title":["Human Papillomavirus Vaccine and Postural Orthostatic Tachycardia Syndrome: A Review of Current Literature"],"prefix":"10.1177","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7094-5937","authenticated-orcid":false,"given":"Breann N.","family":"Butts","sequence":"first","affiliation":[{"name":"Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip R.","family":"Fischer","sequence":"additional","affiliation":[{"name":"Mayo Clinic Division of General Pediatric & Adolescent Medicine, Rochester, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth J.","family":"Mack","sequence":"additional","affiliation":[{"name":"Mayo Clinic Division of Child & Adolescent Neurology, Rochester, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2017,7,10]]},"reference":[{"key":"bibr1-0883073817718731","unstructured":"Human papillomavirus (HPV) and cervical cancer: fact sheet N\u00b0380. World Health Organization 2016; http:\/\/www.who.int\/mediacentre\/factsheets\/fs380\/en\/. Accessed March 15, 2016."},{"key":"bibr2-0883073817718731","unstructured":"HPV vaccine information for clinicians. Centers for Disease Control and Prevention 2016; http:\/\/www.cdc.gov\/hpv\/hcp\/need-to-know.pdf. Accessed March 15, 2016."},{"issue":"05","key":"bibr3-0883073817718731","first-page":"1","volume":"63","author":"Markowitz LE","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"bibr4-0883073817718731","unstructured":"Human papillomavirus (HPV) vaccine background paper. World Health Organization 2008; http:\/\/www.who.int\/immunization\/documents\/HPVBGpaper_final_03_04_2009.pdf. Accessed March 15, 2016."},{"key":"bibr5-0883073817718731","unstructured":"Cervarix: highlights of prescribing information. [Package insert]. GlaxoSmithKline 2009; http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM186981.pdf. Accessed March 15, 2016."},{"key":"bibr6-0883073817718731","unstructured":"Gardasil: highlights of prescribing information. [Package insert]. Merck & Co., Inc. http:\/\/www.merck.com\/product\/usa\/pi_circulars\/g\/gardasil\/gardasil_pi.pdf. Published 2006. Accessed March 15, 2016."},{"key":"bibr7-0883073817718731","unstructured":"Gardasil 9: highlights of prescribing information. [Package insert]. Merck & Co., Inc. https:\/\/www.merck.com\/product\/usa\/pi_circulars\/g\/gardasil_9\/gardasil_9_pi.pdf. Published 2014. Accessed March 15, 2016."},{"key":"bibr8-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061741"},{"key":"bibr9-0883073817718731","unstructured":"Vaccine Adverse Event Reporting System (VAERS). US Department of Health and Human Services 2017; https:\/\/vaers.hhs.gov\/index. Accessed March 16, 2016."},{"key":"bibr10-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2011.08.054"},{"key":"bibr11-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1016\/j.cppeds.2013.12.014"},{"key":"bibr12-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.07.005"},{"key":"bibr13-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2016.02.035"},{"key":"bibr14-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)61027-6"},{"key":"bibr15-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201200049"},{"key":"bibr16-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000755"},{"key":"bibr17-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03021.x"},{"key":"bibr18-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12272"},{"key":"bibr19-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1177\/2324709614527812"},{"key":"bibr20-0883073817718731","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.53.3133"},{"key":"bibr21-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.03.098"},{"key":"bibr22-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.05.029"},{"key":"bibr23-0883073817718731","first-page":"A5064","volume":"62","author":"Brinth L","year":"2015","journal-title":"Dan Med J"},{"key":"bibr24-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8855-1"},{"key":"bibr25-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3070-3"},{"key":"bibr26-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316629558"},{"key":"bibr27-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2011.02467.x"},{"key":"bibr28-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1001\/archpediatrics.2012.1451"},{"key":"bibr29-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-016-0456-3"},{"key":"bibr30-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2015.1073710"},{"key":"bibr31-0883073817718731","unstructured":"Chustecka Z. Japan scheme for managing symptoms after HPV vaccine. Medscape Medical News. http:\/\/www.medscape.com\/viewarticle\/850436. Published September 2015. Accessed March 15, 2016."},{"key":"bibr32-0883073817718731","unstructured":"Chustecka Z. Safety profile of HPV vaccines under review in Europe. Medscape Medical News. http:\/\/www.medscape.com\/viewarticle\/847841. Published July 2015. Accessed March 15, 2016."},{"key":"bibr33-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-2969-z"},{"key":"bibr34-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21407"},{"key":"bibr35-0883073817718731","unstructured":"McCulloch v. Secretary of Health and Human Services. United States Court of Federal Claims, 09-293V. https:\/\/ecf.cofc.uscourts.gov\/cgi-bin\/show_public_doc?2009vv0293-152-0. Published May 22, 2015. Accessed April 19, 2017."},{"key":"bibr36-0883073817718731","unstructured":"L.A.M. v. Secretary of Health and Human Services. United States Court of Federal Claims, 11-852V. https:\/\/ecf.cofc.uscourts.gov\/cgi-bin\/show_public_doc?2011vv0852-131-0. Published January 31, 2017. Accessed April 19, 2017."},{"key":"bibr37-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-004-0288-5"},{"key":"bibr38-0883073817718731","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.54.4479"},{"key":"bibr39-0883073817718731","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.54.4644"},{"key":"bibr40-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.10.013"},{"key":"bibr41-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3090-z"},{"key":"bibr42-0883073817718731","unstructured":"Centers for Disease Control and Prevention. Recommended immunization schedule for persons aged 0 through 18 years, United States. http:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/child-adolescent.html. Published 2017. Accessed March 16, 2016."},{"key":"bibr43-0883073817718731","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12155"},{"key":"bibr44-0883073817718731","unstructured":"Wilson RP, Paterson P, Larson HJ. The HPV vaccination in Japan: issues and options. Centers for Disease Control and Prevention website. http:\/\/csis.org\/files\/publication\/140514_Wilson_HPVVaccination_Web.pdf. Published 2014. Accessed March 22, 2016."},{"key":"bibr45-0883073817718731","unstructured":"Japanese Ministry of Health, Labour and Welfare. The public hearing on adverse events following HPV vaccine in Japan. http:\/\/www.mhlw.go.jp\/stf\/shingi\/0000048229.html. Published 2014. Accessed August 25, 2016."},{"key":"bibr46-0883073817718731","unstructured":"Danish Health and Medicines Authority. Danish pharmacovigilance update: The HPV vaccine and reported suspected adverse reactions. https:\/\/laegemiddelstyrelsen.dk\/en\/news\/2014\/\u223c\/media\/0540230CC7344D6589018F88BB171F51.ashx. Published 2014. Accessed March 16, 2016."},{"key":"bibr47-0883073817718731","unstructured":"European Medicines Agency. Review concludes evidence does not support that HPV vaccines cause CRPS or POTS. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2015\/11\/news_detail_002429.jsp&mid=WC0b01ac058004d5c1. Published May 2015. Accessed March 16, 2016."},{"key":"bibr48-0883073817718731","first-page":"30","volume":"2","author":"Jefferson T","year":"2017","journal-title":"Indian J Med Ethics"},{"key":"bibr49-0883073817718731","unstructured":"Human papillomavirus vaccines: WHO position paper, May 2017. Wkly Epidemiol Rec. 2017;92:241\u2013268. http:\/\/apps.who.int\/iris\/bitstream\/10665\/255353\/1\/WER9219.pdf?ua=1. Accessed May 23, 2017."},{"key":"bibr50-0883073817718731","unstructured":"La Vigne P. HPV vaccines raise international red flags. The Vaccine Reaction. http:\/\/www.thevaccinereaction.org\/2015\/10\/hpv-vaccines-raise-international-red-flags\/. Published October 2015. Accessed March 17, 2016."},{"key":"bibr51-0883073817718731","unstructured":"Health Resources & Services Administration, US Department of Health and Human Services. About the National Vaccine Injury Compensation Program. http:\/\/www.hrsa.gov\/vaccinecompensation\/about\/index.html. Published 2016. Accessed March 16, 2016."},{"key":"bibr52-0883073817718731","unstructured":"SaneVax, Inc. SaneVax: safe, affordable, necessary & effective vaccines and vaccination practices. http:\/\/sanevax.org\/. Accessed March 16, 2016."},{"key":"bibr53-0883073817718731","volume-title":"Adverse Effects of Vaccines: Evidence and Causality","author":"Institute of Medicine","year":"2011"}],"container-title":["Journal of Child Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0883073817718731","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0883073817718731","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0883073817718731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:39:16Z","timestamp":1777495156000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0883073817718731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,10]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1177\/0883073817718731"],"URL":"https:\/\/doi.org\/10.1177\/0883073817718731","relation":{},"ISSN":["0883-0738","1708-8283"],"issn-type":[{"value":"0883-0738","type":"print"},{"value":"1708-8283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,10]]}}}